ProfileGDS4132 / 227743_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 80% 83% 82% 73% 70% 76% 80% 86% 79% 62% 56% 64% 80% 61% 51% 54% 62% 85% 74% 50% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101272.72880
GSM201543Muscle PCOS pioglitazone 121278.71383
GSM201544Muscle PCOS pioglitazone 161316.39882
GSM201545Muscle PCOS pioglitazone 201239.49773
GSM201829Muscle PCOS pioglitazone 231218.47470
GSM201830Muscle PCOS pioglitazon 251246.11176
GSM201831Muscle PCOS pioglitazone 271282.0580
GSM201832Muscle PCOS pioglitazone 31340.89586
GSM201833Muscle PCOS pioglitazone 41259.92879
GSM201834Muscle PCOS pioglitazone 81174.30662
GSM201835Muscle PCOS after pioglitazone 102139.92256
GSM201836Muscle PCOS after pioglitazone 122176.63164
GSM201837Muscle PCOS after pioglitazone 162265.90580
GSM201838Muscle PCOS after pioglitazone 202161.20761
GSM201839Muscle PCOS after pioglitazone 232130.70651
GSM201840Muscle PCOS after pioglitazone 252142.38254
GSM201841Muscle PCOS after pioglitazone 272159.3462
GSM201842Muscle PCOS after pioglitazone 32319.53785
GSM201843Muscle PCOS after pioglitazone 42229.45574
GSM201844Muscle PCOS after pioglitazone 82132.17650